Planet 13 Holdings (PLNH) Share-based Compensation (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Share-based Compensation of $694263.0 for Q1 2026, up 1050.76% year-over-year from $60331.0 in Q1 2025, and down 40.26% quarter-over-quarter from $1.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Share-based Compensation (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Share-based Compensation for 6 consecutive years, with $694263.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 1050.76% year-over-year to $694263.0; the TTM figure through Mar 2026 stood at $3.0 million (up 2079.31% YoY), while the FY2025 annual figure was $2.3 million, up 1195.83% from the prior year.
- Share-based Compensation slipped to $694263.0 in Q1 2026 per PLNH's latest filing, from $1.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.1 million in Q2 2022 and bottomed at -$980189.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $635356.1 across 5 years, with a median of $616654.0 in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 175.11% — and 2025, when it jumped 4472.91%.
- Planet 13 Holdings' Share-based Compensation stood at $1.3 million in 2022, then sank by 175.11% to -$980189.0 in 2023, then soared by 102.59% to $25415.0 in 2024, then surged by 4472.91% to $1.2 million in 2025, then tumbled by 40.26% to $694263.0 in 2026.
- Business Quant data shows PLNH's Share-based Compensation at $694263.0 in Q1 2026, $1.2 million in Q4 2025, and $616654.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | 661,230.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 661,230.00 |
| Jun 30, 2026 | 661,230.00 |
| Mar 31, 2026 | 694,263.00 |
| Mar 31, 2026 | 694,263.00 |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 616,654.00 |
| Sep 30, 2025 | 616,654.00 |
| Jun 30, 2025 | 497,296.00 |
| Jun 30, 2025 | 497,296.00 |
| Mar 31, 2025 | 60,331.00 |
| Mar 31, 2025 | 60,331.00 |
| Dec 31, 2024 | 25,415.00 |
| Dec 31, 2024 | 25,415.00 |
| Sep 30, 2024 | 25,416.00 |
| Sep 30, 2024 | 25,416.00 |
| Jun 30, 2024 | 25,139.00 |
| Jun 30, 2024 | 25,139.00 |
| Mar 31, 2024 | 104,338.00 |
| Mar 31, 2024 | 104,338.00 |